SBTX.L

SkinBioTherapeutics Plc
SkinBioTherapeutics - Holding(s) in Company
12th December 2024, 14:45
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 9122P
SkinBioTherapeutics PLC
12 December 2024
 

TR-1: Standard form for notification of major holdings

 

 

NOTIFICATION OF MAJOR HOLDINGS(to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)


1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

 

SkinBioTherapeutics plc

Company No: 09632164 (England)

 

 

1b. Please indicate if the issuer is a non-UK issuer(please mark with an "X" if appropriate)

Non-UK issuer


2. Reason for the notification(please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments


An event changing the breakdown of voting rights

 

Other (please specify):


3. Details of person subject to the notification obligation

Name

Optibiotix Health PLC

City and country of registered office (if applicable)

York (UK)

4. Full name of shareholder(s)(if different from 3.)

Name


City and country of registered office (if applicable)


5. Date on which the threshold was crossed or reached:

10 December 2024

6. Date on which issuer notified (DD/MM/YYYY):

12 December 2024

7. Total positions of person(s) subject to the notification obligation


 

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments

(total of 8.B 1 + 8.B 2)

 

Total of both in % (8.A + 8.B)

 

Total number of voting rights held in issuer (8.A + 8.B) vii

Resulting situation on the date on which threshold was crossed or reached

 

9.58%

 


 

9.58%

 

 

 

21,884,389


Position of previous notification (if applicable)

 

10.92%

 


 

10.92%

 

24,940,639

 

 

 

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

A: Voting rights attached to shares

Class/type of shares

ISIN code (if possible)

Number of voting rights

% of voting rights

Direct

(DTR5.1)

Indirect

(DTR5.2.1)

Direct

(DTR5.1)

Indirect

(DTR5.2.1)

Ordinary

21,884,389


9.58%


 










SUBTOTAL 8. A

21,884,389

9.58%


B 1: Financial Instruments according to DTR5.3.1R (1) (a)

 

Type of financial instrument

 

Expiration date x

 

Exercise/ Conversion Period xi

Number of voting rights that may be acquired if the instrument is exercised/converted.

 

 

% of voting rights

















SUBTOTAL 8. B 1




B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)

Type of financial instrument

Expiration date x

Exercise/ Conversion Period xi

Physical or cash Settlement xii

Number of voting rights

 

% of voting rights




















SUBTOTAL 8.B.2



 

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii

X

Full chain of controlled undertakings through which the voting rights and/or the

financial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) xiv


 

 

Name

 

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

 

Total of both if it equals or is higher than the notifiable threshold






















10. In case of proxy voting, please identify:

Name of the proxy holder


The number and % of voting rights held


The date until which the voting rights will be held



11. Additional information



Place of completion

London

Date of completion

11 December 2024

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLTTBITMTIBBTI]]>
TwitterFacebookLinkedIn